Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

ByZachary Zubulake

August 19th 2026

Glowing neural network inside a transparent antibiotic capsule surrounded by a large language model on a black background. Illustration of the concept of AI assistance in pharmacy and drug discovery | Image Credit: ©Dragon Claws -stock.adobe.com

How AI Can Assist with Post-Marketing Changes

ByBeena Wood

August 19th 2026

A treatment for erythropoietic protoporphyria and X-linked protoporphyria is pending approval from the FDA.

Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing

ByZachary Zubulake

August 18th 2026

How China's biotech surge is reshaping US drug licensing, manufacturing control, and FDA data trust, the key shifts pharma professionals must track.

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

ByZachary Zubulake,Saharsh Davuluri,John Stanford

August 18th 2026

Glenn Herring, Technical Operations Consultant, Halo

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

ByGlenn Herring,Zachary Zubulake

August 17th 2026

Regulatory and Standard Setting Organizations

Articles in this issue

Related Content

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

How AI Can Assist with Post-Marketing Changes

Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

Trending on Pharmaceutical Technology

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations

Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy

Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing

Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models